Health Care Costs Associated With Norovirus at the Veterans Health Administration
This study found norovirus to be a substantial economic burden in the VHA. Developing targeted interventions, such as vaccines and antivirals, for this population may result in cost savings.
Authors
- Jordan Cates (ORCID: https://orcid.org/0000-0003-4300-7416)
- Umesh D. Parashar (ORCID: https://orcid.org/0000-0002-9684-9425)
- Richard E. Nelson (ORCID: https://orcid.org/0000-0002-4441-7460)
- Mark Holodniy (ORCID: https://orcid.org/0000-0002-6655-7982)
- Cynthia Lucero‐Obusan (ORCID: https://orcid.org/0000-0003-4378-5293)
- Ying Suo (ORCID: https://orcid.org/0000-0002-3563-5300)
- Sara A. Mirza (ORCID: https://orcid.org/0000-0003-3144-6569)
Institutions
- Centers for Disease Control and Prevention (US)
- University of Utah (US)
- VA Salt Lake City Healthcare System (US)
- Department of Veterans Affairs (AU)
- Stanford University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.36600
- Primary Topic
- Viral gastroenteritis research and epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Veterans Affairs
- Centers for Disease Control and Prevention